CD4 and B-cell chronic lymphocytic leukemia: For instance, we showed that lenalidomide markedly increased the activation and proliferation of CD4 T cells and NK cells in CLL [115,116], as its effect on NK cells was mainly due to the induction of IL-2 production by CD4 T cells [115,116].